Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Solis Pharma Us, Inc. (NONE) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Solis Pharma Us, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1559060.
Total stock buying since 2013: $0.
Total stock sales since 2013: $28,812,008,820.
Total stock option exercises since 2013: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2013 | 0 | $0 | 29,400,009 | $28,812,008,820 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2013-09 | 0 | $0 | 29,400,009 | $28,812,008,820 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-09-30 | Mb Americus Llc (Other) | Sale | 9 | 980.00 | 8,820 |
2013-09-30 | Mckillop James K (Other) | Sale | 9,800,000 | 980.00 | 9,604,000,000 |
2013-09-30 | Tiber Creek Corp (Other) | Sale | 9,800,000 | 980.00 | 9,604,000,000 |
2013-09-30 | Cassidy James M (Other) | Sale | 9,800,000 | 980.00 | 9,604,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NONE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Solis Pharma Us, Inc. (symbol NONE, CIK number 1559060) see the Securities and Exchange Commission (SEC) website.